 SAN DIEGO, Jan. 28, 2021 GLOBE NEWSWIRE -- GBT Technologies Inc. OTC PINK: GTCH GBT, or the Company announced today that GBT Tokenize Corp GBTTokenize engaged M Squared Associates M2 to assist with developing the FDA premarket strategy for its qTerm device. For more than 20 years, M2 has been providing a full range of regulatory, quality and clinical consulting services to US and international medical technology firms. M2 specializes in devices, biologics and combination products that are reviewed by FDAs Center for Devices and Radiological Health CDRH. 